Using rapid extracellular antigen profiling (REAP), a group at Yale University detected enrichment of autoantibodies against IL-6 in patients with severe and moderate COVID-19 compared to people with asymptomatic infection or no infection [82]. This evidence concerns the gene IL6 and COVID-19.